Comparison of Outcomes When Switching Treatment From Intravitreal Bevacizumab to Ranibizumab in Neovascular Age-Related Macular Degeneration

被引:0
|
作者
Kent, J. S. [1 ]
Lordanous, Y. [1 ]
Mao, A. [1 ]
Shukla, S. [1 ]
Sheidow, T. [1 ]
机构
[1] Univ Western Ontario, Dept Ophthalmol, London, ON, Canada
关键词
age-related macular degeneration; clinical (human) or epidemiologic studies: outcomes/complications; vascular endothelial growth factor;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
82
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration
    Kent, Jerrod S.
    Iordanous, Yiannis
    Mao, Alex
    Powell, Anne-Marie
    Kent, Shefalee Shukla
    Sheidow, Tom G.
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2012, 47 (02): : 159 - 164
  • [2] Comparison of outcomes after switching treatment from intravitreal bevacizumab or ranibizumab to aflibercept in neovascular age-related macular degeneration
    Venzara, Frank
    Mason, John
    Glover, Jay
    McGwin, Gerald
    Huisingh, Carrie
    Friedman, Duncan
    Feist, Richard
    Thomley, Martin
    Albert, Michael
    Price, Natalie
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [3] COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Stepien, Kimberly E.
    Rosenfeld, Philip J.
    Puliafito, Carmen A.
    Feuer, William
    Shi, Wei
    Al-Attar, Luma
    Dubovy, Sander R.
    Murray, Timothy G.
    Davis, Janet L.
    Lee, Wen-Hsiang
    Schwartz, Stephen G.
    Smiddy, William E.
    Berrocal, Audina M.
    Flynn, Harry W., Jr.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (08): : 1067 - 1073
  • [4] Switch from Intravitreal Ranibizumab to Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration: Clinical Comparison
    Pinheiro-Costa, Joao
    Freitas-da-Costa, Paulo
    Falcao, Manuel S.
    Brandao, Elisete M.
    Falcao-Reis, Fernando
    Carneiro, Angela M.
    [J]. OPHTHALMOLOGICA, 2014, 232 (03) : 149 - 155
  • [5] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Florian M. Heussen
    Qing Shao
    Yanling Ouyang
    Antonia M. Joussen
    Bert Müller
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 909 - 915
  • [6] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    [J]. OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [7] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Heussen, Florian M.
    Shao, Qing
    Ouyang, Yanling
    Joussen, Antonia M.
    Mueller, Bert
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (06) : 909 - 915
  • [8] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Park, Dae Hyun
    Sun, Hae Jung
    Lee, Sung Jin
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (05) : 1205 - 1214
  • [9] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Dae Hyun Park
    Hae Jung Sun
    Sung Jin Lee
    [J]. International Ophthalmology, 2017, 37 : 1205 - 1214
  • [10] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Feng, Xue-Feng
    Constable, Ian J.
    McAllister, Ian L.
    Isaacs, Timothy
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (01) : 85 - 88